We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What is happening with the new healthcare bill? Simply stated...it's complicated.
As I put my commentary to bed on Thursday night there was continued wrangling to get the bill passed in Congress. However the vote scheduled for Thursday is being delayed. That is typically a sign that they don't have enough votes to pass at this time. But it also tells you that the next time they set a date for a vote, then odds of passage are high.
Interestingly, the Trump team is wisely pivoting on the narrative. That being a failure to get it passed is not a statement of administration incompetence. Rather, it is about Democrats being obstructionists to improving a flawed healthcare program.
I don't point this out to start a political battle. Or to say who is right. Rather, the perception of what happens with this bill has ripple effects to the stock market. That is because, as stated in my last commentary, the prevailing narrative goes as follows:
If the Trump team can't get a victory on the repeal of Obamacare on Thursday, then the odds of success on also getting lower taxes and higher infrastructure spending are greatly diminished.
So if they successfully change the perception that failure is not on the administration, then it may not lead to concerns on their ability to pass pro-growth agenda and what that means for the market. Then again, they could just make some additional compromises to get the votes necessary to pass the bill.
Simply stated...it's complicated.
Best,
Steve Reitmeister
Executive Vice President, Zacks Investment Research
On Monday morning, Zacks' computer-generated "Black Box" strategy will release its next batch of stocks and trigger a wave of buying among a select group of investors.
Over a 10-year testing period, this secret formulation of stock traits produced a flurry of quick winners, more than doubling the S&P. Today you can be first in line for next week's picks.
Follow your investments easily in one place. Get free email updates that alert you to major events affecting your stocks and funds, including timely recommendation changes, earnings announcements and, most importantly, earnings estimate revisions.